3.0
27. Dez. 2008
Mitarbeiter (anonym)
Aktueller Mitarbeiter
Empfehlen
CEO-Befürwortung
Geschäftsprognose
Pros
Coloplast sells products (ostomy, urology, skin and wound care) which make a difference in patient lives. Products are excellent quality.
Kontras
Strategic changes occur more rapidly than allow for evaluation of success/failure of the prior strategy. Market issues in the US are not as well understood at headquarters (Denmark) as desirable which impacts plans and policies. Market share in some business units is so small that it is difficult to get traction to significantly increase market share. Selling through distributors adds obstacles, timing issues, and of course adds costs.